Search for: "Long v. Janssen Research "
Results 1 - 20
of 22
Sorted by Relevance
|
Sort by Date
14 Jan 2014, 9:30 am
However, in keeping with Janssen Inc v Teva (supra), I find that there is also a requirement to provide evidence that the research is relevant. [read post]
1 Apr 2024, 10:58 am
Janssen Pharms., Inc. v. [read post]
2 Jul 2014, 1:42 pm
Janssen Biotech and Centocor Biologics (Fed. [read post]
7 Nov 2008, 3:42 am
No problem: In re Ciprofloxacin Hydrochloride Antitrust Litigation (Patent Baristas) US: FTC Commissioner speaks out on follow-on biologics – current initiatives and long-term goals (FDA Law Blog) US: Hatch-Waxman Act-related lawsuits likely to drop, but generic companies may start to challenge biotechnology patents, says David Pritikin (Law360) US: Sequenom sues rival genetic research company Ibis Biosciences alleging infringement of DNA analysis patents (Law360)… [read post]
8 Dec 2023, 7:58 am
Janssen, 2014). [read post]
6 Dec 2021, 6:24 am
Phase 2/3 clinical trials began in February 2021 for Pfizer/BioNTech and Janssen and included pregnant people. [read post]
30 May 2017, 5:17 am
For those further interested in jurisprudence on what the Supreme Court of Canada recently referred to as “the long tradition of judicial copying”, see Cojocaru v. [read post]
30 May 2017, 5:17 am
For those further interested in jurisprudence on what the Supreme Court of Canada recently referred to as “the long tradition of judicial copying”, see Cojocaru v. [read post]
21 Apr 2017, 6:25 am
Brinckerhoff v. [read post]
21 Apr 2017, 6:25 am
Brinckerhoff v. [read post]
18 Nov 2016, 12:44 am
The judge held that the “undue burden” concept in English law (particularly as outlined by Arnold J in Eli Lilly v Janssen in 2014) was not particularly helpful under Australian law. [read post]
5 Sep 2013, 12:24 pm
Ortho-McNeil-Janssen Pharmaceuticals, Inc., 808 F. [read post]
6 Jul 2007, 4:29 am
See Larkin v. [read post]
9 Nov 2015, 7:39 am
The judge explained that such uncertainty in a scientific area does not stop the knowledge being part of the CGK, so long as the area of debate is well-defined (see paras [24] and [87]). [read post]
16 May 2013, 2:09 pm
Ortho-McNeil-Janssen Pharmaceuticals, 2013 Phila. [read post]
12 Apr 2007, 1:33 am
See State v. [read post]
29 Aug 2016, 1:19 pm
Risperdal is the name Janssen patented and used when marketing the product. [read post]
1 Oct 2009, 2:14 am
It offered "substantial authority" that the "plain meaning" of §1441(b) "establishes that, so long as [defendant] removed this case prior to being served with process, removal was proper. [read post]
29 Feb 2008, 8:00 am
– Teva’s opposition proceedings regarding IL 130424 to Pfizer: (IP Factor), Thailand: Thai chief drug price negotiator removed from post: (GenericsWeb), Thailand: Compulsory licences cannot be revoked: (Generic Pharmaceuticals & IP), (more from Generic Pharmaceuticals & IP), UK: Court of Appeal for England and Wales hands down decision in Boehringer Ingelheim KG and Boehringer Ingelheim Pharma KG v Swingward Limited relating to repackaging and… [read post]
12 Sep 2008, 2:33 pm
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Australian Review of National Innovation System released: (IPRoo), (Mallesons Stephen Jaques), (creativecommons.org), (IP Menu News), Senate Committee on the Judiciary approval of Enforcement of Intellectual Property Rights Act 2008 and surrounding debate (Law360), (Public Knowledge), (Ars Technica), (Wired), (Public Knowledge), (Ars Technica),… [read post]
